Lymphoma, Leukemia & Myeloma Congress News

faculty headshot
Mapping Early Myeloma: How New Research Is Changing Our Understanding of Disease Progression
For years, clinicians have relied on established categories such as monoclonal gammopathy of undetermined significance (MGUS), smoldering
Blog
HMP Global’s LL&M Congress Celebrates 25 Years of Innovation in Hematology Oncology with 25+ New Faculty Experts for 2025
Held October 14-17 in New York City, LL&M Congress offers updates for hematologists, oncologists, APPs, and multidisciplinary
LL&M Congress 2025: 25 Years of Progress, Connection, and the Future of Hematology
Marking a milestone in advancing science, sharing knowledge, and shaping the next generation of blood cancer care. Over the
AML Transplant Decisions in 2026: Who Still Needs a Stem Cell Transplant?
Allogeneic stem cell transplantation remains one of the most powerful tools for preventing relapse in acute myeloid leukemia
Is DLBCL Entering the Post-R-CHOP Era?
For more than two decades, R-CHOP has been the standard frontline treatment for diffuse large B-cell lymphoma (DLBCL)

All Content

The 26th LL&M Congress is moving to New York Marriott Marquis October 13-16
HMP Global’s 2026 LL&M Congress Marks 26th Year of Clinically Actionable Leukemia, Lymphoma, and Myeloma Education
Annual meeting moves to the New York Marriott Marquis on October 13-16, marking a new chapter and providing a refreshed setting for in
Press Release
Attendees in session at LL&M Congress 2025
HMP Global’s 2026 LL&M Congress Marks 26th Year of Clinically Actionable Leukemia, Lymphoma, and Myeloma Education
Annual meeting moves to the New York Marriott Marquis on October 13-16, marking a new chapter and providing a refreshed setting for in
Press Release
LL&M Congress attendees in general session.
LL&M Congress: Translating research into practical applications
Working together to advance the treatment of hematologic malignancies, improve quality of life, and better patient outcomes. Research is at
Blog
LL&M Congress speakers at general session
LL&M Congress 2025: 25 Years of Progress, Connection, and the Future of Hematology
Marking a milestone in advancing science, sharing knowledge, and shaping the next generation of blood cancer care. Over the past 25 years
Press Release
Back to top